CPGR, SimuGen Enter Into Biomarker Assay Pact

The South African non-profit organization will team with the Malaysian pharmacogenomics firm to develop biomarker assays for the prediction of toxicity of existing and new drug compounds.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories